Universität zu Köln

Bleeker, Gitta, van Eck-Smit, Berthe L., Zwinderman, Koos H., Versteeg, Rogier ORCID: 0000-0001-7172-0388, van Noesel, Max M., Kam, Boen L., Kaspers, Gertjan J., van Schie, Annelies, Kreissman, Susan G., Yanik, Gregory, Hero, Barbara, Schmidt, Matthias, Laureys, Genevieve, Lambert, Bieke, Ora, Ingrid ORCID: 0000-0002-3931-4125, Schulte, Johannes H., Caron, Huib N. and Tytgat, Godelieve A. (2015). MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. Eur. J. Nucl. Med. Mol. Imaging, 42 (2). S. 222 - 231. NEW YORK: SPRINGER. ISSN 1619-7089

Molenaar, Jan J., Domingo-Fernandez, Raquel, Ebus, Marli E., Lindner, Sven, Koster, Jan ORCID: 0000-0002-0890-7585, Drabek, Ksenija, Mestdagh, Pieter, van Sluis, Peter, Valentijn, Linda J., van Nes, Johan ORCID: 0000-0001-7691-1431, Broekmans, Marloes, Haneveld, Franciska, Volckmann, Richard, Bray, Isabella, Heukamp, Lukas ORCID: 0000-0002-3388-3482, Spruessel, Annika, Thor, Theresa, Kieckbusch, Kristina, Klein-Hitpass, Ludger, Fischer, Matthias, Vandesompele, Jo ORCID: 0000-0001-6274-0184, Schramm, Alexander ORCID: 0000-0001-7670-7529, van Noesel, Max M., Varesio, Luigi, Speleman, Frank, Eggert, Angelika ORCID: 0000-0003-3476-8184, Stallings, Raymond L., Caron, Huib N., Versteeg, Rogier ORCID: 0000-0001-7172-0388 and Schulte, Johannes H. (2012). LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nature Genet., 44 (11). S. 1199 - 1207. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1546-1718

van Wezel, Esther M., Decarolis, Boris ORCID: 0000-0002-1607-0543, Stutterheim, Janine, Zappeij-Kannegieter, Lily, Berthold, Frank ORCID: 0000-0002-7613-1723, Schumacher-Kuckelkorn, Roswitha, Simon, Thorsten, Fiocco, Marta, van Noesel, Max M., Caron, Huib N., van der Schoot, C. Ellen, Hero, Barbara and Tytgat, Godelieve A. M. (2016). Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients. Eur. J. Cancer, 54. S. 149 - 159. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

van Wezel, Esther M., Stutterheim, Janine, Vree, Florentien, Zappeij-Kannegieter, Lily, Decarolis, Boris ORCID: 0000-0002-1607-0543, Hero, Barbara, Berthold, Frank, Schumacher-Kuckelkorn, Roswitha, Simon, Thorsten, Fiocco, Marta, Voermans, Carlijn, van Noesel, Max M., Caron, Huib N., van der Schoot, C. Ellen and Tytgat, Godelieve A. M. (2015). Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma. Pediatr. Blood Cancer, 62 (8). S. 1368 - 1374. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017

van Wezel, Esther M., van Zogchel, Lieke M. J., van Wijk, Jalenka, Timmerman, Ilse, Vo, Ngoc-Kim, Zappeij-Kannegieter, Lily, DeCarolis, Boris, Simon, Thorsten, van Noesel, Max M., Molenaar, Jan J., van Groningen, Tim, Versteeg, Rogier, Caron, Huib N., van der Schoot, C. Ellen, Koster, Jan, van Nes, Johan and Tytgat, Godelieve A. M. (2019). Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel. JCO Precis. Oncol., 3. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 2473-4284